[Clinical study of panipenem/betamipron for burn infections in the domain of plastic and reconstructive surgery].
Abstract
The effectiveness and the safety of panipenem/betamipron, new antibiotics of the carbapenems for burn infections, were studied and the following results were obtained: 1. The preparation, 0.5 g/0.5 g, was administered by intravenous drip infusion twice a day to 11 cases of patients with burn infections. In 10 cases for which clinical effects were evaluable, results were rated as "excellent" in 2 cases, "good" in 2 cases and "fair" in 6 cases, with an efficacy rate of 40%. 2. Penetration to the affected tissue was studied in 2 cases. The tissue level of panipenem was 0.20 micrograms/g immediately after the end of drip infusion and 6.86 micrograms/g 60 minutes thereafter. 3. As for the safety, a slight increase in GOT, GPT and Al-P was noted in 1 case; a slight increase in GPT, NAG and beta 2MG was found in 1 case; and a slight increase in GOT, GPT, Al-P and LAP was noted in 1 case, as abnormal variations in laboratory test results.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | intravenous
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | beta 2MG
|
scispacy | 1 | ||
| 약물 | panipenem/betamipron
|
scispacy | 1 | ||
| 약물 | panipenem
|
C0207932
panipenem
|
scispacy | 1 | |
| 약물 | Al-P
|
scispacy | 1 | ||
| 약물 | GOT
|
scispacy | 1 | ||
| 약물 | GPT
|
scispacy | 1 | ||
| 약물 | NAG
|
scispacy | 1 | ||
| 질환 | infections
|
C0851162
Infections of musculoskeletal system
|
scispacy | 1 | |
| 질환 | burn infections
|
C0548923
burn infection
|
scispacy | 1 | |
| 질환 | abnormal variations
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | GPT
|
scispacy | 1 | ||
| 기타 | LAP
|
scispacy | 1 |
MeSH Terms
Adolescent; Aged; Aged, 80 and over; Burns; Child; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Skin Diseases, Infectious; Surgery, Plastic; Thienamycins; Tissue Distribution; Wound Infection; beta-Alanine